ReviewBMC medicine2014
Personalized medicine: risk prediction, targeted therapies and mobile health technology.
Review in BMC medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed.
- The effect of mobile personalised texting versus non-personalised texting on the caries risk of underprivileged adults: a randomised control trial.BMC oral health · 2019Trial
- Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials.BMC medical research methodology · 2017Trial
- The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patients treated in primary care.BMC pulmonary medicine · 2014Trial
- MELD score is predictive of postoperative morbidity and mortality in patients with acute appendicitis undergoing appendectomy: ACS-NSQIP data analysis.Surgical endoscopy · 2026Article
- Reducing inequalities using an unbiased machine learning approach to identify births with the highest risk of preventable neonatal deaths.Population health metrics · 2025Article
- The Role of Monoclonal Antibodies as Therapeutics in HPV-Related Head and Neck Cancers: An Updated Review.Antibodies (Basel, Switzerland) · 2025Review
- Sophorolipids as anticancer agents: progress and challenges.Discover oncology · 2025Review
- Effect of the Big Five Personality on the intention to use mHealth applications among the Chinese elderly: a national-based study.Frontiers in psychology · 2025Article
- Cariogram-based Comparison of Caries Risk Profile in Preschoolers Before and After Giving Parent-oriented Educational Mobile Messages: A Randomized Controlled Trial.International journal of clinical pediatric dentistry · 2025Article
- Aging precisely: Precision medicine through the lens of an older adult.Journal of the American Geriatrics Society · 2024Review
- Review
- Personalized Mobile Health for Elderly Home Care: A Systematic Review of Benefits and Challenges.International journal of telemedicine and applications · 2023Review
- Bone turnover markers can predict healing time in medication-related osteonecrosis of the jaw.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Nursing Personnel in the Era of Personalized Healthcare in Clinical Practice.Journal of personalized medicine · 2020Review
- Collaborative Multi-Expert Active Learning for Mobile Health Monitoring: Architecture, Algorithms, and Evaluation.Sensors (Basel, Switzerland) · 2020Article
- A Digital Diabetes Prevention Program (Transform) for Adults With Prediabetes: Secondary Analysis.JMIR diabetes · 2019Article
- Study of Out-Of-Hospital Access to HIS System: A Security Perspective.Sensors (Basel, Switzerland) · 2019Article
- The Iterative Convergent Design for Mobile Health Usability Testing: Mixed Methods Approach.JMIR mHealth and uHealth · 2019Article
- Value of pre-operative CTX serum levels in the prediction of medication-related osteonecrosis of the jaw (MRONJ): a retrospective clinical study.The EPMA journal · 2019Article
- Mobile-based insulin dose adjustment for type 2 diabetes in community and rural populations: study protocol for a pilot randomized controlled trial.Therapeutic advances in endocrinology and metabolism · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Personalized medicine is increasingly being employed across many areas of clinical practice, as genes associated with specific diseases are discovered and targeted therapies are developed. Mobile apps are also beginning to be used in medicine with the aim of providing a personalized approach to disease management. In some areas of medicine, patient-tailored risk prediction and treatment are applied routinely in the clinic, whereas in other fields, more work is required to translate scientific advances into individualized treatment. In this forum article, we asked specialists in oncology, neurology, endocrinology and mobile health technology to discuss where we are in terms of personalized medicine, and address their visions for the future and the challenges that remain in their respective fields.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.